Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Synthesis of potential estrogen-receptor based tumor-specific radiopharmaceuticals

Thesis/Dissertation ·
OSTI ID:5698067
Procedures were developed to label analogues of the nonsteroidal estrogen hexestrol with /sup 75/Se. Labeling was accomplished by substitution of divalent selenium for methylene. 1-Iodo-2,3-diphenylpentane and 1-iodo-2,3-bis(4-methoxyphenyl)pentane were synthesized and converted to their corresponding diselenides using NaH/sup 75/Se as nucleophile. The NaH/sup 75/Se was generated from (/sup 75/Se)selenious acid using NaBH/sub 4/ at pH 6.0. 1-(/sup 125/I)iodo-2,3-bis(4-methoxyphenyl)pentane was obtained from 2,3-bis(4-methoxyphenyl)pentane was obtained from 2,3-bis(4-methoxyphenyl)pentylmethanesulfonate using Na/sup 125/I in refluxing acetone. The cyclopropyl compound 1,1-dichloro-2,3-diphenylcyclotpropane was labeled with /sup 125/I at the 4-position on the aromatic ring. Labelling was accomplished by reacting 2,1-stilbeneazopyrrolidine synthesized from 4-nitrostilbene with Na/sup 125/I. Biodistribution studies in mature and immature female Sprague Dawley rats showed that the 1-methyl-(/sup 75/Se)seleno-2,3-bis(4-methoxyphenyl)pentane obtained slightly higher uterine-to-blood ratios and uterine tissue concentrations than did the other compounds.
Research Organization:
Oklahoma Univ., Oklahoma City (USA). Health Sciences Center
OSTI ID:
5698067
Country of Publication:
United States
Language:
English